5 research outputs found

    Minimizing the Ground Effect for Photophoretically Levitating Disks

    Full text link
    Photophoretic levitation is a propulsion mechanism in which lightweight objects can be lifted and controlled through their interactions with light. Since photophoretic forces on macroscopic objects are usually maximized at low pressures, they may be tested in vacuum chambers in close proximity to the chamber floor and walls. We report here experimental evidence that the terrain under levitating microflyers, including the chamber floor or the launchpad from which microflyers lift off, can greatly increase the photophoretic lift forces relative to their free-space (mid-air) values. To characterize this so-called "ground effect" during vacuum chamber tests, we introduced a new miniature launchpad composed of three J-shaped (candy-cane-like) wires that minimized a microflyer's extraneous interactions with underlying surfaces. We compared our new launchpads to previously used wire-mesh launchpads for simple levitating mylar-based disks with diameters of 2, 4, and 8 cm. Importantly, wire-mesh launchpads increased the photophoretic lift force by up to sixfold. A significant ground effect was also associated with the bottom of the vacuum chamber, particularly when the distance to the bottom surface was less than the diameter of the levitating disk. We provide guidelines to minimize the ground effect in vacuum chamber experiments, which are necessary to test photophoretic microflyers intended for high-altitude exploration and surveillance on Earth or on Mars.Comment: 7 pages, 7 figures, including the Supplemental Materia

    Small molecule inhibitors of Aβ-aggregation and neurotoxicity

    Get PDF
    Alzheimer disease (AD) is characterized pathologically by extracellular amyloid deposits composed of Aβ peptide, neurofibrillary tangles (NFTs) made up of hyperphosphorylated tau, and a deficit of cholinergic neurons in the basal forebrain. Presently, only symptomatic therapies are available for the treatment of AD and these therapies have a limited time frame of utility. Amyloid disorders represent the effects of chronic Aβ production and are not a secondary pathological effect caused by a distant trigger; therefore targeting Aβ is a viable pursuit. In this review, we will discuss the various small molecule anti-aggregation inhibitors that have been reported in the literature, with emphasis on compounds that are presently being investigated in clinical trials

    Measurement of vector boson production cross sections and their ratios using pp collisions at √s = 13.6 TeV with the ATLAS detector

    Get PDF
    Abstract available from publisher's website
    corecore